January Therapeutics
Norm Herman has joined January as an advisor for CMC/Formulation/Partnership Relations. Norm has over 25+ years in pharmaceutical development and manufacturing, specializing in oral dosage product development and drug delivery manufacturing.
Norm’s previous work at Halozyme contributed to very successful partnering deals with their technology to numerous companies. His other successes at Purdue Pharma, and Lederle have helped shaped his understanding of drug delivery.
This person is not in any teams
January Therapeutics
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties.